Preliminary	Preliminary	JJ	B-NP	O	
X-ray	X-ray	NN	I-NP	O	
crystallographic	crystallographic	JJ	I-NP	O	
analysis	analysis	NN	I-NP	O	
of	of	IN	B-PP	O	
β	β	AFX	B-NP	B-cell_line	
-	-	HYPH	I-NP	O	
carbonic	carbonic	JJ	B-NP	B-protein	
anhydrase	anhydrase	NN	I-NP	I-protein	
psCA3	psCA3	NN	I-NP	I-protein	
from	from	IN	B-PP	O	
Pseudomonas aeruginosa	Pseudomonas_aeruginosa	NNP	B-NP	O	
.	.	.	O	O	

Pseudomonas aeruginosa	Pseudomonas_aeruginosa	NNP	B-NP	O	
is	be	VBZ	B-VP	O	
a	a	DT	B-NP	O	
Gram	Gram	NN	I-NP	O	
-	-	HYPH	B-NP	O	
negative	negative	JJ	I-NP	O	
bacterium	bacterium	NN	I-NP	O	
that	that	WDT	B-NP	O	
causes	cause	VBZ	B-VP	O	
life	life	NN	B-NP	O	
-	-	HYPH	O	O	
threatening	threaten	VBG	B-VP	O	
infections	infection	NNS	B-NP	O	
in	in	IN	B-PP	O	
susceptible	susceptible	JJ	B-NP	O	
individuals	individual	NNS	I-NP	O	
and	and	CC	O	O	
is	be	VBZ	B-VP	O	
resistant	resistant	JJ	B-ADJP	O	
to	to	TO	B-PP	O	
most	most	RBS	B-ADVP	O	
clinically	clinically	RB	I-ADVP	O	
available	available	JJ	B-NP	O	
antimicrobials	antimicrobial	NNS	I-NP	O	
.	.	.	O	O	

Genomic	Genomic	JJ	B-NP	O	
and	and	CC	I-NP	O	
proteomic	proteomic	JJ	I-NP	O	
studies	study	NNS	I-NP	O	
have	have	VBP	B-VP	O	
identified	identify	VBN	I-VP	O	
three	three	CD	B-NP	O	
genes	gene	NNS	I-NP	O	
,	,	,	I-NP	O	
pa0102	pa0102	NN	I-NP	O	
,	,	,	I-NP	O	
pa2053	pa2053	NN	I-NP	O	
and	and	CC	I-NP	O	
pa4676	pa4676	NN	I-NP	O	
,	,	,	O	O	
in	in	IN	B-PP	O	
P. aeruginosa	P._aeruginosa	NNP	B-NP	O	
PAO1	PAO1	NN	I-NP	B-protein	
encoding	encode	VBG	B-VP	O	
three	three	CD	B-NP	O	
functional	functional	JJ	I-NP	O	
β	β	AFX	I-NP	O	
-	-	HYPH	I-NP	O	
carbonic	carbonic	JJ	I-NP	B-protein	
anhydrases	anhydras	NNS	I-NP	I-protein	
(	(	(	O	O	
β	β	AFX	B-NP	B-cell_line	
-	-	HYPH	I-NP	O	
CAs	CA	NNS	I-NP	O	
)	)	)	O	O	
:	:	:	O	O	
psCA1	psCA1	NN	B-NP	B-protein	
,	,	,	I-NP	O	
psCA2	psCA2	NN	I-NP	B-protein	
and	and	CC	I-NP	O	
psCA3	psCA3	NN	I-NP	B-protein	
,	,	,	O	O	
respectively	respectively	RB	B-ADVP	O	
.	.	.	O	O	

These	These	DT	B-NP	O	
β	β	AFX	I-NP	B-cell_line	
-	-	HYPH	I-NP	O	
CAs	CA	NNS	I-NP	O	
could	could	MD	B-VP	O	
serve	serve	VB	I-VP	O	
as	as	IN	B-PP	O	
novel	novel	JJ	B-NP	O	
antimicrobial	antimicrobial	JJ	I-NP	O	
drug	drug	NN	I-NP	O	
targets	target	NNS	I-NP	O	
for	for	IN	B-PP	O	
this	this	DT	B-NP	O	
pathogen	pathogen	NN	I-NP	O	
.	.	.	O	O	

X-ray	X-ray	NN	B-NP	O	
crystallographic	crystallographic	JJ	I-NP	O	
structural	structural	JJ	I-NP	O	
studies	study	NNS	I-NP	O	
have	have	VBP	B-VP	O	
been	be	VBN	I-VP	O	
initiated	initiate	VBN	I-VP	O	
to	to	TO	I-VP	O	
characterize	characterize	VB	I-VP	O	
the	the	DT	B-NP	O	
structure	structure	NN	I-NP	O	
and	and	CC	I-NP	O	
function	function	NN	I-NP	O	
of	of	IN	B-PP	O	
these	these	DT	B-NP	O	
proteins	protein	NNS	I-NP	O	
.	.	.	O	O	

This	This	DT	B-NP	O	
communication	communication	NN	I-NP	O	
describes	describe	VBZ	B-VP	O	
the	the	DT	B-NP	O	
production	production	NN	I-NP	O	
of	of	IN	B-PP	O	
two	two	CD	B-NP	O	
crystal	crystal	JJ	I-NP	O	
forms	form	NNS	I-NP	O	
(	(	(	O	O	
A	A	NN	B-NP	O	
and	and	CC	O	O	
B	B	NN	B-NP	O	
)	)	)	O	O	
of	of	IN	B-PP	O	
β	β	AFX	B-NP	B-protein	
-	-	HYPH	I-NP	I-protein	
CA	CA	NN	I-NP	I-protein	
psCA3	psCA3	NN	I-NP	I-protein	
.	.	.	O	O	

Form	Form	NN	B-NP	O	
A	A	NN	I-NP	O	
diffracted	diffract	VBN	B-VP	O	
to	to	TO	B-PP	O	
a	a	DT	B-NP	O	
resolution	resolution	NN	I-NP	O	
of	of	IN	B-PP	O	
2.9	2.9	CD	B-NP	O	
Å	Å	NN	I-NP	O	
;	;	:	O	O	
it	it	PRP	B-NP	O	
belonged	belong	VBD	B-VP	O	
to	to	TO	I-VP	O	
space	space	VB	I-VP	O	
group	group	NN	B-NP	O	
P212121	P212121	NN	I-NP	O	
,	,	,	O	O	
with	with	IN	B-PP	O	
unit	unit	NN	B-NP	O	
-	-	HYPH	B-NP	O	
cell	cell	NN	I-NP	O	
parameters	parameter	NNS	I-NP	O	
a	a	DT	B-NP	O	
=	=	JJ	I-NP	O	
81.9	81.9	CD	I-NP	O	
,	,	,	O	O	
b	b	NN	B-NP	B-protein	
=	=	SYM	B-VP	I-protein	
84.9	84.9	CD	B-NP	I-protein	
,	,	,	O	O	
c	c	NN	B-NP	O	
=	=	SYM	B-VP	O	
124.2	124.2	CD	B-NP	O	
Å	Å	NN	I-NP	O	
,	,	,	O	O	
and	and	CC	O	O	
had	have	VBD	B-VP	O	
a	a	DT	B-NP	O	
calculated	calculate	VBN	I-NP	O	
Matthews	Matthews	NNP	I-NP	O	
coefficient	coefficient	NN	I-NP	O	
of	of	IN	B-PP	O	
2.23	2.23	CD	B-NP	B-protein	
Å³	Å³	NNP	I-NP	I-protein	
Da⁻¹	Da⁻¹	NNP	I-NP	I-protein	
assuming	assume	VBG	B-VP	I-protein	
four	four	CD	B-NP	I-protein	
molecules	molecule	NNS	I-NP	I-protein	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
crystallographic	crystallographic	JJ	I-NP	O	
asymmetric	asymmetric	JJ	I-NP	O	
unit	unit	NN	I-NP	O	
.	.	.	O	O	

Form	Form	NN	B-NP	O	
B	B	NN	I-NP	O	
diffracted	diffract	VBD	B-VP	O	
to	to	TO	B-PP	O	
a	a	DT	B-NP	O	
resolution	resolution	NN	I-NP	O	
of	of	IN	B-PP	O	
3.0	3.0	CD	B-NP	O	
Å	Å	NN	I-NP	O	
;	;	:	O	O	
it	it	PRP	B-NP	O	
belonged	belong	VBD	B-VP	O	
to	to	TO	I-VP	O	
space	space	VB	I-VP	O	
group	group	NN	B-NP	O	
P21212	P21212	NN	I-NP	O	
,	,	,	O	O	
with	with	IN	B-PP	O	
unit	unit	NN	B-NP	O	
-	-	HYPH	B-NP	O	
cell	cell	NN	I-NP	O	
parameters	parameter	NNS	I-NP	O	
a	a	DT	B-NP	O	
=	=	JJ	I-NP	O	
69.9	69.9	CD	I-NP	O	
,	,	,	O	O	
b	b	NN	B-NP	B-protein	
=	=	SYM	B-VP	I-protein	
77.7	77.7	CD	B-NP	I-protein	
,	,	,	O	O	
c	c	NN	B-NP	B-protein	
=	=	SYM	B-VP	I-protein	
88.5	88.5	CD	B-NP	I-protein	
Å	Å	NN	I-NP	I-protein	
,	,	,	O	O	
and	and	CC	O	O	
had	have	VBD	B-VP	O	
a	a	DT	B-NP	O	
calculated	calculate	VBN	I-NP	O	
Matthews	Matthews	NNP	I-NP	O	
coefficient	coefficient	NN	I-NP	O	
of	of	IN	B-PP	O	
2.48	2.48	CD	B-NP	O	
Å³	Å³	NNP	I-NP	O	
Da⁻¹	Da⁻¹	NNP	I-NP	O	
assuming	assume	VBG	B-VP	O	
two	two	CD	B-NP	O	
molecules	molecule	NNS	I-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
crystallographic	crystallographic	JJ	I-NP	O	
asymmetric	asymmetric	JJ	I-NP	O	
unit	unit	NN	I-NP	O	
.	.	.	O	O	

Preliminary	Preliminary	JJ	B-NP	O	
molecular	molecular	JJ	I-NP	O	
-	-	HYPH	I-NP	O	
replacement	replacement	NN	I-NP	O	
solutions	solution	NNS	I-NP	O	
have	have	VBP	B-VP	O	
been	be	VBN	I-VP	O	
determined	determine	VBN	I-VP	O	
with	with	IN	B-PP	O	
the	the	DT	B-NP	O	
PHENIX	PHENIX	NN	I-NP	O	
AutoMR	AutoMR	NN	I-NP	O	
wizard	wizard	NN	I-NP	O	
and	and	CC	I-NP	O	
refinement	refinement	NN	I-NP	O	
of	of	IN	B-PP	O	
both	both	DT	B-NP	O	
crystal	crystal	JJ	I-NP	O	
forms	form	NNS	I-NP	O	
is	be	VBZ	B-VP	O	
currently	currently	RB	B-ADVP	O	
in	in	IN	B-PP	O	
progress	progress	NN	B-NP	O	
.	.	.	O	O	

